AIMS/HYPOTHESIS: Dietary sugar intake may increase insulin production, stress the beta cells and increase the risk for islet autoimmunity (IA) and subsequent type 1 diabetes. METHODS: Since 1993, the Diabetes Autoimmunity Study in the Young (DAISY) has followed children at increased genetic risk for type 1 diabetes for the development of IA (autoantibodies to insulin, GAD or protein tyrosine phosphatase-like protein [IA2] twice or more in succession) and progression to type 1 diabetes. Information on intake of fructose, sucrose, total sugars, sugar-sweetened beverages, beverages with non-nutritive sweetener and juice was collected prospectively throughout childhood via food frequency questionnaires (FFQs). We examined diet records for 1,893 children (mean age at last follow-up 10.2 years); 142 developed IA and 42 progressed to type 1 diabetes. HLA genotype was dichotomised as high risk (HLA-DR3/4,DQB1*0302) or not. All Cox regression models were adjusted for total energy, FFQ type, type 1 diabetes family history, HLA genotype and ethnicity. RESULTS: In children with IA, progression to type 1 diabetes was significantly associated with intake of total sugars (HR 1.75, 95% CI 1.07-2.85). Progression to type 1 diabetes was also associated with increased intake of sugar-sweetened beverages in those with the high-risk HLA genotype (HR 1.84, 95% CI 1.25-2.71), but not in children without it (interaction p value = 0.02). No sugar variables were associated with IA risk. CONCLUSIONS/ INTERPRETATION: Sugar intake may exacerbate the later stage of type 1 diabetes development; sugar-sweetened beverages may be especially detrimental to children with the highest genetic risk of developing type 1 diabetes.
AIMS/HYPOTHESIS: Dietary sugar intake may increase insulin production, stress the beta cells and increase the risk for islet autoimmunity (IA) and subsequent type 1 diabetes. METHODS: Since 1993, the Diabetes Autoimmunity Study in the Young (DAISY) has followed children at increased genetic risk for type 1 diabetes for the development of IA (autoantibodies to insulin, GAD or protein tyrosine phosphatase-like protein [IA2] twice or more in succession) and progression to type 1 diabetes. Information on intake of fructose, sucrose, total sugars, sugar-sweetened beverages, beverages with non-nutritive sweetener and juice was collected prospectively throughout childhood via food frequency questionnaires (FFQs). We examined diet records for 1,893 children (mean age at last follow-up 10.2 years); 142 developed IA and 42 progressed to type 1 diabetes. HLA genotype was dichotomised as high risk (HLA-DR3/4,DQB1*0302) or not. All Cox regression models were adjusted for total energy, FFQ type, type 1 diabetes family history, HLA genotype and ethnicity. RESULTS: In children with IA, progression to type 1 diabetes was significantly associated with intake of total sugars (HR 1.75, 95% CI 1.07-2.85). Progression to type 1 diabetes was also associated with increased intake of sugar-sweetened beverages in those with the high-risk HLA genotype (HR 1.84, 95% CI 1.25-2.71), but not in children without it (interaction p value = 0.02). No sugar variables were associated with IA risk. CONCLUSIONS/ INTERPRETATION:Sugar intake may exacerbate the later stage of type 1 diabetes development; sugar-sweetened beverages may be especially detrimental to children with the highest genetic risk of developing type 1 diabetes.
Authors: L A Velloso; E Björk; A E Ballagi; K Funa; A Andersson; O Kämpe; F A Karlsson; D L Eizirik Journal: Mol Cell Endocrinol Date: 1994-06 Impact factor: 4.102
Authors: Jill M Norris; Katherine Barriga; Georgeanna Klingensmith; Michelle Hoffman; George S Eisenbarth; Henry A Erlich; Marian Rewers Journal: JAMA Date: 2003-10-01 Impact factor: 56.272
Authors: Jennifer M Barker; Katherine J Barriga; Liping Yu; Dongmei Miao; Henry A Erlich; Jill M Norris; George S Eisenbarth; Marian Rewers Journal: J Clin Endocrinol Metab Date: 2004-08 Impact factor: 5.958
Authors: E Björk; O Kämpe; F A Karlsson; D G Pipeleers; A Andersson; C Hellerström; D L Eizirik Journal: J Clin Endocrinol Metab Date: 1992-12 Impact factor: 5.958
Authors: Randi K Johnson; Lauren A Vanderlinden; Brian C DeFelice; Ulla Uusitalo; Jennifer Seifert; Sili Fan; Tessa Crume; Oliver Fiehn; Marian Rewers; Katerina Kechris; Jill M Norris Journal: Pediatr Diabetes Date: 2020-08-09 Impact factor: 4.866
Authors: Karl Mårild; Fran Dong; Nicolai A Lund-Blix; Jennifer Seifert; Anna E Barón; Kathleen C Waugh; Iman Taki; Ketil Størdal; German Tapia; Lars C Stene; Randi K Johnson; Edwin Liu; Marian J Rewers; Jill M Norris Journal: Am J Gastroenterol Date: 2019-08 Impact factor: 10.864
Authors: Patrick M Carry; Lauren A Vanderlinden; Randi K Johnson; Teresa Buckner; Oliver Fiehn; Andrea K Steck; Katerina Kechris; Ivana Yang; Tasha E Fingerlin; Marian Rewers; Jill M Norris Journal: Diabetes Date: 2021-04-16 Impact factor: 9.337
Authors: Randi K Johnson; Roy Tamura; Nicole Frank; Ulla Uusitalo; Jimin Yang; Sari Niinistö; Carin Andrén Aronsson; Anette-G Ziegler; William Hagopian; Marian Rewers; Jorma Toppari; Beena Akolkar; Jeffrey Krischer; Suvi M Virtanen; Jill M Norris Journal: Diabetologia Date: 2021-03-30 Impact factor: 10.460